Two-Drug HIV Therapy Reaches Lymph Node Reservoirs, Trial Imaging Shows
A randomized trial combining in situ viral imaging and mass spectrometry shows that first-line dolutegravir/lamivudine therapy penetrates lymph node tissue ...
A randomized trial combining in situ viral imaging and mass spectrometry shows that first-line dolutegravir/lamivudine therapy penetrates lymph node tissue ...
Dolutegravir, one of the most widely prescribed antiretroviral drugs in the world, may interfere with the developing heart and blood ...
A 48-week prospective cohort study finds that switching men with HIV off tenofovir disoproxil fumarate to TAF-based or tenofovir-free regimens, ...
A combined animal and clinical study finds that the standard TLD antiretroviral regimen disrupts estrous cycling, damages ovarian tissue, and ...
A cross-sectional study of 171 Zimbabwean adults on dolutegravir-based HIV therapy found dyslipidaemia in 74.3 percent and insulin resistance in ...
A prospective cohort of 396 newly diagnosed patients at a Casablanca tertiary care center reveals widespread late presentation, heavy tuberculosis ...
A cross-sectional study of 54 HIV-positive adults with type 2 diabetes at Uganda's Lira Regional Referral Hospital finds that glycemic ...
A study of more than 17,000 patients in Benin found about 91 percent viral suppression on dolutegravir-based therapy, with marked ...
A three-year retrospective study of 2,379 people with HIV in China found that switching from older antiretroviral therapy to INSTI-based ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine